Celanese Corporation
NYSE:CEChemicals
-$0.24 today
- Market cap
- $5.29B
- Beta
- 0.74
- P/E (TTM)
- -5.1
- EPS (TTM)
- -$9.98
- Dividend yield
- 0.24%
Volume 1.38M
Average 2.09M
CE Operating Income
Profit from core operations after operating expenses, before interest and taxes.
Celanese CorporationNYSE: CE
Operating Income · Q2 FY2026 · quarter ended Jun 2026
Operating income growth accelerates
Q2 FY2026 operating income of $276M rose 18.5% year over year, ahead of the +9.8% change in trailing-twelve-month operating income. Sequentially, it rose 46.0% from the prior quarter. Over 3 fiscal years it compounded at -17.7% a year.
Context
- Operating income amounted to 8.0% of revenue in FY2025, up 1.3 pp from a year earlier.
- Operating income increased in 2 of the last 3 fiscal years.
What to watch
Whether operating income reaches the consensus estimate from 12 analysts of $1.58B (+106.1%) for the fiscal year ending Dec 2026, a slowdown from the +210.0% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $276M+46.0% QoQ
- Last fiscal yearDec 2025
- $767M+210.0% YoY
- LTMJun 2026
- -$682M+9.8% YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Income history
USD · from the income statement
- Latest · FY2025
- 767M USD
- Year-over-year change
- +210.0%
- 4-year CAGR
- -20.8%
| Period | Period end | Operating Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 767M | +210.0% |
| FY2024 | 2024-12-31 | (697M) | -141.3% |
| FY2023 | 2023-12-31 | 1.69B | +22.4% |
| FY2022 | 2022-12-31 | 1.38B | -29.2% |
| FY2021 | 2021-12-31 | 1.95B | — |
Operating Income vs competitors
How CE compares with its peers on the latest reported figures
- Peers report in different currencies, so operating income is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +9.8% is the 8th highest of 11, against a peer median of +16.9%.
- Operating income amounts to 7.0% of revenue for CE, versus a peer median of 14.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2026 | ZAR 55.77B ZAR | +45.0% | +0.8% | 20.9% | |
| LTM Jun 2026 | $841.02M USD | +283.7% | +36.0% | 43.5% | |
| LTM Mar 2026 | $616.26M USD | +257.8% | +70.2% | 47.5% | |
| LTM Jun 2026 | $501M USD | -21.0% | +16.9% | 13.8% | |
| LTM Aug 2026 | $409.65M USD | +16.4% | +7.4% | 11.5% | |
| LTM Jun 2026 | $239.32M USD | +17.5% | +1.7% | 14.0% | |
| LTM Sep 2026 | $237.35M USD | +16.1% | +14.6% | 21.4% | |
| LTM Jun 2026 | $135M USD | +51.7% | — | 7.3% | |
| LTM Sep 2026 | $121.47M USD | +0.8% | +9.3% | 10.7% | |
| LTM Mar 2026 | -$156.02M USD | -109.1% | — | — | |
| LTM Jun 2026 | -$682M USD | +9.8% | -17.7% | 7.0% | |
| Peer median (excluding CE) | — | +16.9% | +11.9% | 14.0% | |
Competitors are the stored peer set for CE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 8.54B | 9.67B | 10.94B | 10.28B | 9.54B |
| Cost of Revenue | 5.86B | 7.29B | 8.34B | 7.92B | 7.75B |
| Gross Profit | 2.68B | 2.38B | 2.6B | 2.36B | 1.79B |
| Gross Margin | 31.4% | 24.6% | 23.8% | 22.9% | 18.8% |
| Research & Development | 86M | 112M | 146M | 130M | 125M |
| Selling, General & Admin | 633M | 824M | 1.08B | 1.03B | 899M |
| Operating Expenses | 736M | 1B | 916M | 3.05B | 1.02B |
| Depreciation & Amortization | 378M | 478M | 711M | 823M | 786M |
| EBITDA | 2.72B | 2.3B | 2.61B | 503M | 335M |
| EBITDA Margin | 31.8% | 23.8% | 23.9% | 4.9% | 3.5% |
| Operating Income | 1.95B | 1.38B | 1.69B | (697M) | 767M |
| Operating Margin | 22.8% | 14.2% | 15.4% | -6.8% | 8.0% |
| Interest Income | 8M | 69M | 39M | 33M | 24M |
| Interest Expense | 100M | 405M | 720M | 676M | 769M |
| Other Income / Expenses | 302M | 43M | (504M) | (299M) | (1.99B) |
| Income Before Tax | 2.25B | 1.42B | 1.18B | (996M) | (1.22B) |
| Pre-Tax Margin | 26.3% | 14.7% | 10.8% | -9.7% | -12.8% |
| Income Tax Expense | 330M | (489M) | (790M) | 510M | (90M) |
| Net Income | 1.89B | 1.89B | 1.96B | (1.52B) | (1.17B) |
| Net Margin | 22.1% | 19.6% | 17.9% | -14.8% | -12.2% |
| EPS (Basic) | 16.99 | 17.48 | 18.01 | (13.93) | (10.64) |
| EPS (Diluted) | 16.86 | 17.34 | 17.92 | (13.93) | (10.64) |
| Weighted Avg Shares | 111.22M | 108.38M | 108.85M | 109.27M | 109.5M |
| Weighted Avg Shares (Diluted) | 112.08M | 109.24M | 109.38M | 109.27M | 109.5M |
Celanese Corporation
NYSE:CE
Intrinsic Alpha fair value
Locked
Current Price
$48.21
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.